Sfmg LLC Buys 19,063 Shares of Healthpeak Properties, Inc. $DOC

Sfmg LLC increased its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 15.0% in the second quarter, HoldingsChannel reports. The fund owned 145,936 shares of the real estate investment trust’s stock after purchasing an additional 19,063 shares during the period. Sfmg LLC’s holdings in Healthpeak Properties were worth $2,555,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Healthpeak Properties by 584.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust’s stock worth $186,405,000 after purchasing an additional 7,872,150 shares during the last quarter. Nuveen LLC purchased a new stake in Healthpeak Properties during the 1st quarter valued at $124,113,000. Invesco Ltd. grew its holdings in Healthpeak Properties by 20.7% in the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock worth $467,311,000 after acquiring an additional 3,967,830 shares during the last quarter. Nordea Investment Management AB increased its position in shares of Healthpeak Properties by 7,444.0% in the second quarter. Nordea Investment Management AB now owns 3,923,205 shares of the real estate investment trust’s stock valued at $67,871,000 after acquiring an additional 3,871,201 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in shares of Healthpeak Properties by 21.5% during the second quarter. JPMorgan Chase & Co. now owns 20,024,030 shares of the real estate investment trust’s stock valued at $350,621,000 after acquiring an additional 3,540,367 shares during the last quarter. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Up 2.5%

NYSE DOC opened at $17.83 on Friday. The company has a current ratio of 1.22, a quick ratio of 1.28 and a debt-to-equity ratio of 1.11. The stock’s 50 day moving average is $18.29 and its 200 day moving average is $17.83. Healthpeak Properties, Inc. has a 12 month low of $16.63 and a 12 month high of $22.71. The stock has a market cap of $12.39 billion, a PE ratio of -356.53, a P/E/G ratio of 3.84 and a beta of 1.10.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.01. The company had revenue of $705.87 million for the quarter, compared to the consensus estimate of $681.65 million. Healthpeak Properties had a negative return on equity of 0.44% and a negative net margin of 1.36%.The firm’s revenue for the quarter was up .8% on a year-over-year basis. During the same period in the previous year, the business earned $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Research analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 19th will be issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 6.8%. The ex-dividend date is Friday, December 19th. Healthpeak Properties’s dividend payout ratio is presently -2,440.00%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on DOC shares. Wells Fargo & Company reduced their price target on Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 27th. Robert W. Baird decreased their target price on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a research report on Wednesday, November 12th. Raymond James Financial raised shares of Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price target for the company in a research report on Monday, September 15th. Evercore ISI set a $22.00 target price on Healthpeak Properties in a research note on Monday, September 15th. Finally, Morgan Stanley decreased their price objective on shares of Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating for the company in a report on Friday, August 22nd. Seven research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Healthpeak Properties presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.82.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.